Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.
Today’s edition tracks the same story from four angles: the federal hemp cap is already reshaping state strategy, New York is testing where low dose THC drinks belong, and the enforcement headlines keep writing talking points for the people who want to rewind the clock. We also cover Ohio’s antitrust shot across the MSO bow, Massachusetts using budget power to keep its regulator on a short leash, and a set of market discipline signals from NYC pricing to cannabis wage compression.
Today’s edition is supported by IT Brew and Masterworks. To sponsor Policy, Decoded and reach the executives, investors, and policymakers who read this briefing, reply to this email and we will send details.
🌾 Hemp Cap Pressure
🥃 Channel Control Tests
🚨 Enforcement Optics
Headlines are easy. Governance is hard.
The news IT leaders crave
If your job touches cybersecurity, software, cloud, or IT operations, staying informed isn’t optional.
IT Brew is a free, four-times-a-week newsletter covering the trends shaping business tech—from infrastructure and strategy to the tools teams actually rely on.
Clear context. Focused coverage. Built for professionals running IT—not just talking about it.

Fast-moving headlines, flagged for what matters.
A new federal definition of legal hemp takes effect November 12, 2026, and it effectively sets a per-container THC ceiling that most mainstream products cannot meet. Colorado growers and manufacturers describe it as commercially unworkable, especially for ingested formats that already carry licensing and independent testing costs. Big Nugget Farms co owner Meagan Agnew told Aspen Public Radio the rule would erase core SKUs in a business that has been trying to professionalize. Hemp Beverage Alliance president Christopher Lackner flagged the downstream hit to small beverage makers and co packers that built capacity on lawful demand. Colorado lawmakers are now chasing state guardrails that look more like cannabis rules, partly to protect consumers and partly to preserve a viable channel while Congress decides whether to blink. (Aspen Public Radio)
A New York Assembly bill, A10191, would allow liquor and wine stores to sell low dose cannabis beverages made by New York adult use licensees. The bill sets a 5 milligram total THC per container limit, requires a separate sales area, and forces inventory into an OCM approved tracking system. Taxes are designed to look familiar and durable, with a 9% tax at distribution and a 13% tax at retail. This is New York acknowledging the hemp beverage debate without saying the quiet part, which is that Washington’s timeline matters and the state wants options. The open question is whether New York’s congressional delegation plans to give its home market any runway, or whether it will help tighten the vise and leave Albany cleaning up the fallout. (Law360)
Craft brewers are using hemp derived THC drinks as a revenue bridge in a brutal beer cycle, with the Brewers Association reporting more closures than openings again in 2025. Indeed Brewing says THC beverages are now a meaningful share of revenue, and operators in Tennessee and Georgia describe sellouts and rapid growth in co manufacturing. The political fight often gets framed as alcohol versus THC, but the reality down the supply chain is more practical: distributors, retailers, and co packers are leaning in because they need volume. The federal cap scheduled for November turns that growth into a planning problem, since compliance can get priced into oblivion overnight. The category is behaving like a real consumer shift, and policy uncertainty is behaving like a kill switch. (The Drinks Business)
Food Dive reports sharp sales increases for THC beverage brands after federal restrictions were teed up for November, with several brands citing double digit lifts tied to publicity and stockpiling behavior. NIQ data in the piece shows the category growing fast, and retailers are responding by adding shelf space while the rules remain unsettled. This is the political trap of a crackdown announcement: it validates demand and accelerates trial, even as it gives lawmakers a rationale to tighten caps and channel controls. Brands will point to consumer adoption and responsible low dose models. Critics will point to proliferation and argue that delay equals permission. The market is moving faster than the statute book, and that gap is where mistakes and headlines get made. (Food Dive)
Ohio Attorney General Dave Yost filed an antitrust case alleging major operators coordinated in 2022 to favor each other’s products and push smaller businesses off shelves. The lawsuit names a roster of large MSOs and frames the conduct as reciprocal purchasing, information sharing, and discriminatory distribution under Ohio’s Valentine Act. The legal merits will take time, but the posture is the point: Ohio has been taking a sharper approach to intoxicants, including cracking down on hemp alongside more assertive cannabis enforcement. This also lands in an election environment where ballot questions and statewide races shape who wants to look tough, fair, or both. If the court entertains injunctive relief, purchasing practices can get disrupted quickly, and everyone will suddenly rediscover their compliance manuals. (Cannabis Business Times)
New York City projects cannabis tax revenue growth through fiscal 2027, with year to date collections up sharply as more stores open. The city also admits a key reality: sales per store have been dropping since late 2025 as prices fall and competition increases. The math is familiar across mature markets, and it is not moral, it is structural: more licenses spread the same demand across more doors, and illicit sellers keep pressure on the legal price. Industry sources argue enforcement against illegal shops would lift the tax take, and they are right in the short term. The longer term issue is whether the city is building a stable revenue stream or a volatile one that gets blamed on the legal market every time projections miss. (New York Post)
WCVB reports Massachusetts has not funded the statutorily required public awareness campaign on marijuana and THC risks since 2018. The CCC has requested the money year after year (I know, I was there), and the line item keeps disappearing even as cannabis tax revenue keeps rolling in. That pattern primarily speaks to governance, since appropriations function as leverage and cannabis remains political currency on Beacon Hill. The Commission’s instinct has often been to point down at staff when commissioners create the controversy, and lawmakers do not reward that dynamic. A public health mandate left unfunded becomes a talking point for prohibition campaigns, and Massachusetts is handing it over without a fight. (WCVB 5 Investigates)
Nebraska lawmakers advanced a narrow bill to patch gaps at the Medical Cannabis Commission, including pay for commissioners, a cash fund, fee authority, and fingerprinting. The unanimous vote reads like recognition that the job is hard and the state has been asking regulators to perform without tools. Underfunding and undercutting does not prevent harm, it simply pushes harm into the shadows where it gets more expensive and less controllable. The commission is still stuck in rollout theater, expected to deliver seriousness on a deadline while politics argues about legitimacy. If Nebraska wants patient safety and market order, it has to resource the boring parts that make both possible. (News From The States)
Virginia’s Cannabis Control Authority launched a public dashboard tracking medical cannabis program activity across sales, pricing, and product trends. That is a governance choice that builds trust because it forces debates to start with shared numbers instead of vibes and anecdotes. Patients benefit from visibility into consistency and availability, and lawmakers benefit from an honest baseline as they argue about expansion and enforcement. Virginia should take the next step and publish comparable transparency for adult use planning whenever it moves, so medical patients do not get treated like legacy infrastructure. Data does not solve politics, but it does make bad arguments more expensive. (Virginia Cannabis Control Authority)
Maine lawmakers are considering requiring mold and chemical contaminant testing for medical cannabis, a baseline that adult use markets already treat as standard. Caregivers warn testing raises costs and could shrink participation, and that concern deserves respect because the medical ecosystem is built on small operators. The public health discomfort remains real: patients should not have to guess whether a product is clean, and a program without testing is asking trust to do the work of science. I used to hear Massachusetts patients talk about crossing borders for better flower, and the quiet answer was always testing and standards. Maine has a choice between preserving an honor system and building a floor that protects patients even when it changes business models. (Portland Press Herald)
Reports on grow houses tied to transnational networks are multiplying, and they are easy stories for national outlets because they combine crime, borders, and cannabis in one frame. The risk is not abstract: large scale diversion undercuts compliant operators, and unsafe cultivation conditions can ride along to consumers. These cases also become ready made content for prohibition campaigns in places like Massachusetts, Arizona, and Washington, because a dramatic bust is simpler than a sober conversation about regulation. Maine’s lighter infrastructure has been a soft target, and the state will face pressure for tighter controls whether it wants them or not. The lesson is that weak systems invite headlines, and headlines invite policy that rarely arrives gently. (NewsNation)
Missouri’s state auditor said early license scoring lacked consistency and transparency, including applicant identifiers creeping into a process meant to be blind. The audit also flagged scoring anomalies that fed years of litigation and costly appeals. I have lived through audits that reviewed every early decision under a microscope, and that experience shapes my view: audits are designed to surface weaknesses, not to validate intent. A defensible agency response treats an audit as a roadmap, not a personal indictment, and uses it to tighten documentation and controls. Missouri’s next test is whether leadership uses the critique to improve process integrity or gets stuck relitigating the past. (Missouri State Auditor’s Office; NewsTalk KZRG)
Chicago City Council members failed to override Mayor Brandon Johnson’s veto of a proposed citywide ban on hemp-derived intoxicating products, leaving the local market intact for now. The underlying ordinance sought to prohibit the sale of hemp THC products in Chicago, even as the state continues to debate broader guardrails. Johnson argued regulation should come through a more coordinated framework rather than a patchwork municipal ban. The failed override signals that even in a large, politically active city, appetite for outright prohibition is limited when consumer demand and retail footprints are already established. The consequence is that Illinois lawmakers now face added pressure to clarify statewide rules, because the absence of a municipal ban keeps the category visible and politically live. (Chicago Sun-Times)
An Oklahoma House committee advanced a bill that would ban medical marijuana gummies in animated shapes and add clearer serving size labeling. The prompt was child exposure concerns raised during Department of Human Services home visits, and the optics are hard to ignore. Serving size clarity is a practical upgrade, and most serious operators already act as if 10 milligrams is the basic reference unit. The trick is enforcement, since shape rules can become a game of loopholes if the rest of packaging and marketing stays loud. This is Oklahoma signaling it wants fewer kid adjacent risks without taking on the full potency fight in one bill. (KOKH FOX 25)
Cannabis employers used wage premiums to recruit steady workers, especially when budtenders were expected to operate like patient facing professionals. Minimum wage floors are rising and the premium is shrinking, which exposes who built a real culture and who relied on novelty. The chief of staff truth is simple: budtenders are often the only human touchpoint a consumer ever has with your brand, and that interaction shapes trust more than your packaging does. Operators with capital will keep paying for retention because churn is expensive and training is compliance. Operators without margin will chase automation and tighter staffing, and service quality will tell on them quickly. (MJBizDaily)
Alex Berenson uses a Fox opinion column to recycle the same thesis he has been selling for years, now framed as validation by a recent New York Times editorial shift. He points to potency and personal testimony and then leaps to banning THC extracts, which is the easiest talking point in the room because it avoids governance. Extract bans do not land like a surgical health measure in regulated markets, they detonate the revenue engine that funds testing, enforcement, and legal alternatives. They also push demand toward the unregulated channels where potency and contamination risks are hardest to control. Adults can have a serious potency conversation, and it still needs to be rooted in calibration, age gating, and market structure rather than book tour prohibition. (Fox News)
Florida agricultural officers said they found 671 pounds of cannabis hidden among orange pallets in a shipment from California. It is an easy story, and it is also an important one because it answers the next question before it gets asked. If product is moving at that weight casually, the illicit channel remains alive, well, and profitable even with state legal markets expanding. This is why enforcement headlines keep returning, and why opponents use them as proof that legalization failed. The more honest lesson is that interstate diversion is still a business model, and no state market has solved it alone. (WEAR-TV)
PIMCO Says 15-25% Alternatives. Now. Here’s A Billionaire’s Pick You Probably Missed.
Analysts at nearly every major bank contend: investors should target 15-25% of their portfolios in inflation hedges. PIMCO. BlackRock. Goldman Sachs.
The problem? TIPS yield only 2.1%. Gold's at all-time highs and volatile. Bitcoin dropped to 1 year lows while pretending to be "digital gold."
Meanwhile, ultra-high-net-worth collectors have an answer. They had 28% allocated to art and collectibles in 2025, according to Deloitte. Not as decoration, but as a long-term working asset.
The growth backs it up. Contemporary art overall outpaced the S&P(!) by 15% from 1995 to 2025.* Low correlation to stocks and bonds. Globally priced. Finite supply. No wonder.
Masterworks lets you fractionally invest in blue-chip art—Banksy, Basquiat, Picasso—without buying the whole painting. 26 exits. Annualized net returns like 14.6%, 17.6%, and 17.8% on works held longer than a year.
Shares in new offerings can sell quickly, but our subscribers get priority access:
*Investing involves risk. Past performance not indicative of future returns. See important disclosures at masterworks.com/cd.
💰 Bayou City Hemp is a brand to watch in Texas and beyond, raising money while federal policy turbulence is getting closer and louder. Growth at this pace requires real distribution relationships and real operational discipline, especially with November 2026 hanging over the category. If they can keep the strategy tight, they will be one of the tells on who survives the next regulatory turn. (StreetInsider)
🚔 New York authorities say they seized about $1.4 million in cannabis during a Brooklyn enforcement action, a reminder that the illicit market still carries scale, cash, and political urgency. The licensed market absorbs the reputational hit when these stories lead the news cycle, even when compliant operators have nothing to do with it. Expect continued enforcement bursts paired with fresh pressure on the state to speed up licensing and retail access. (Brooklyn Eagle)
🤖 AI in cannabis marketing will keep improving, and the risk is treating it as a compliance substitute instead of a compliance tool. I am biased as an advisor, and I am also aware of how technical cannabis rules can get when you cross state lines or platform policies. The winners will use automation to support disciplined review, not to outsource judgment. (StupidDOPE)
⚽ Jamaica is leaning into global identity for the 2026 World Cup with Bob Marley inspired kits that turn a soccer jersey into a cultural flag. It is a reminder that brand power travels faster than policy and it shows up in places regulators never control. (High Times)
🏌️ Eighth Iron is blending cannabis and golf culture in a way that feels less rebellious and more recreational mainstream. When lifestyle brands normalize the pairing quietly, policy debates about where consumption belongs tend to follow. (High Times)





